Highlights
NASDAQ: TSRO       Tesaro Inc
Last Price Today's Change   Day's Range   Trading Volume
114.82   +1.22 (1.07%)  112.83 - 115.09  218,520

Overview

 
Avg Volume (4 weeks):533,870
4 Weeks Range:112.83 - 129.64
4 Weeks Price Volatility (%):
11.84%
52 Weeks Range:106.64 - 192.94
52 Weeks Price Volatility (%):
9.48%
Average Price Target: 70.00
Price Target Upside/Downside: -44.82

Headlines



No recent Headlines for this stock.


Business Background

TESARO, Inc. is an oncology-focused biopharmaceutical company. The Company operates through the business of developing and commercializing of oncology-focused therapeutics segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform. Rolapitant is a potent and long-acting neurokinin-1 receptor antagonist for the prevention of chemotherapy induced nausea and vomiting. Niraparib is an orally active and potent poly (adenosine diphosphate (ADP)-ribose) polymerase inhibitor. It has various ongoing clinical trials evaluating niraparib for the treatment of ovarian or breast cancers. It has initiated a Phase I, dose escalation study for its first immuno-oncology antibody, TSR-042, which targets Programmed cell death protein 1. It has commenced pre-clinical research for its antibody candidate targeting Lymphocyte-activation gene-3 andTSR-033. It has commenced a Phase I clinical trial of TSR-042.

  Be the first to like this.
 


 

3943  3133  565  814 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 GE 23.64+0.52 
 SPY 255.455-0.265 
 BAC 26.49+0.01 
 MU 40.97-0.68 
 EEM 46.03-0.47 
 VXX 34.93+0.29 
 ADHD 1.594+0.324 
 AAPL 155.396-4.364 
 UVXY 16.307+0.237 
 UGAZ 10.119-0.111 
Partners & Brokers